Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT) has appointed Dr. Ashiq H. Khan as EVP global head, chief commercial officer (CCO).
Dr. Khan brings more than 15 years of international leadership experience in biotech, CRO and AI-driven platform businesses to Evotec. He previously served as chief business officer at Iktos.
In a statement, Dr. Christian Wojczewski, CEO of Evotec, commented, “Ashiq has demonstrated tremendous success driving growth in innovative areas like robotics, artificial intelligence and cutting-edge drug discovery platforms. His expertise is essential for executing the next stage of Evotec’s transformation as a responsive drug discovery and development engine built around high-value services and capabilities. We are excited to have someone with his experience in recognizing and creating new opportunities at the helm of our commercial team.”
